TNF and Alzheimer disease: To date, TNF-neutralizing agents are effective in treating PSO (26) [etanercept (54), infliximab (55), adalimumab (56), and certolizumab pegol (57)], whereas others report their possible efficacy in SLE (58) and AD (59, 60).